Armistice Capital’s Dermata Therapeutics, Inc. Warrant DRMAW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,354
| Closed | -$14 | – | 239 |
|
|
2024
Q4 | $14 | Buy |
+1,354
| New | +$14 | ﹤0.01% | 226 |
|
|
2024
Q2 | – | Sell |
-20,312
| Closed | -$193 | – | 289 |
|
|
2024
Q1 | $193 | Sell |
20,312
-304,688
| -94% | -$2.9K | ﹤0.01% | 331 |
|
|
2023
Q4 | $142 | Buy |
325,000
+304,687
| +1,500% | +$133 | ﹤0.01% | 288 |
|
|
2023
Q3 | $355 | Hold |
20,313
| – | – | ﹤0.01% | 248 |
|
|
2023
Q2 | $508 | Sell |
20,313
-1
| -0% | – | ﹤0.01% | 216 |
|
|
2023
Q1 | $1.01K | Sell |
20,314
-304,686
| -94% | -$15.2K | ﹤0.01% | 222 |
|
|
2022
Q4 | $4.75K | Hold |
325,000
| – | – | ﹤0.01% | 190 |
|
|
2022
Q3 | $31K | Hold |
325,000
| – | – | ﹤0.01% | 190 |
|
|
2022
Q2 | $36 | Hold |
325,000
| – | – | ﹤0.01% | 173 |
|
|
2022
Q1 | $52K | Hold |
325,000
| – | – | ﹤0.01% | 137 |
|
|
2021
Q4 | $140K | Hold |
325,000
| – | – | ﹤0.01% | 141 |
|
|
2021
Q3 | $270K | Buy |
+325,000
| New | +$270K | ﹤0.01% | 132 |
|